Mar 24, 1976

Dibenzepin and amitriptyline in depressive states: comparative double-blind trial

The New Zealand Medical Journal
M Gowardman, R A Brown

Abstract

Dibenzepin and amitriptyline appeared to be equally efficacious in controlling target symptoms of depressive reactions. These results appear to be consistent with pharmacological profiles of the two drugs which are both tricylic compounds. Control of target symptoms occurred in an undulating and non-progressive manner in both groups. Aggravation of depressive symptomatology in the third week of treatment was noted in both groups and appeared to be clinically very important in the management of depressed patients. Dibenzepin caused relatively fewer side effects which appears to be an advantage over amitriptyline. Dibenzepin appeared to be a suitable alternative for amitriptyline intolerant patients, with moderately severe depression associated with anxiety, especially patients who demonstrated emotional sensitivity or passive dependent personality, and psychosomatic symptoms.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Depressed - Symptom
Amitriptyline Hydrochloride
Depressive Symptoms
Clinical Trials
Dibenzazepines
Amitriptyline
Anxiety Disorders
Amitriptyline Measurement
Factor Construct Rating Scales (Fcrs)
Personality Disorders

About this Paper

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.